Product Program year 2024 Source: CMS Open Payments

Cardiomems

Device Heart failure

PDI 05414734509800

Open in the dashboard

General payments

$4,848,900

51,604 payments

Research payments

$5,170,981

1,378 payments

Through program year 2024, $4,848,900 in general payments and $5,170,981 in research payments were reported against Cardiomems (Heart failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2024 General $1,588,085 15,796
2024 Research $974,485 105
2023 General $1,751,650 18,808
2023 Research $2,073,835 527
2022 General $1,509,165 17,000
2022 Research $2,122,662 746

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $4,848,900 51,604 payments
Top recipients General payments · program year 2024
  1. Cleveland Clinic Hospital Teaching hospital · OH $80,175 5% · 2 payments
  2. Patrick McCann Advanced Heart Failure and Transplant Cardiology · Columbia, SC $45,311 3% · 96 payments
  3. Aman Shah Cardiovascular Disease · Roslyn, NY $39,873 3% · 65 payments
  4. Inova Loudoun Hospital Center Teaching hospital · VA $35,583 2% · 1 payment
  5. Scott Lundgren Advanced Heart Failure and Transplant Cardiology · Omaha, NE $32,180 2% · 59 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Advanced Heart Failure and Transplant Cardiology Internal Medicine $332,270 25% · 398 practitioners
  2. Cardiovascular Disease Internal Medicine $289,075 22% · 1,417 practitioners
  3. Interventional Cardiology Internal Medicine $122,960 9% · 753 practitioners
  4. Nurse Practitioner $101,059 8% · 488 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $85,060 6% · 641 practitioners

The top 5 of 127 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Texas $213,401 13% · 826 recipients
  2. New York $184,454 12% · 550 recipients
  3. Ohio $118,826 7% · 252 recipients
  4. Illinois $86,039 5% · 447 recipients
  5. California $79,979 5% · 407 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

51,604 general · 1,378 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record